Cancer of unknown primary (CUP) presents one of the most complex and under-addressed challenges in oncology today. Characterised by metastatic disease with no identifiable site of origin, CUP accounts for 2-5% of all cancer diagnoses globally and is often associated with poor prognosis, limited
No takes yet. Share an insight, caveat, or question.
Andhale et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: